A transaction of over 10000 crores and it occupied most part of the business newspapers. Guess its really worth.
Daiichi Sankyo, Japan's third largest pharmaceutical company announced that it will acquire the entire shareholding of the Sellers in Ranbaxy and further seek to acquire the majority of the voting capital of Ranbaxy at a price of Rs 737 per share with the total transaction value expected to be between US $3.4 to US $4.6 billion.
This is the largest transaction involving an Indian pharmaceutical company. Daiichi initiated the bid and this will catapult Daiichi to become the 15th biggest drugmaker in the world from the current 22 and give access to 60 countries from the present 15.
Indian pharma industry has for sure got some good lessons from this acquistition.
Is this something referred to as "a deal like never before" ?!
